How to use the speech recognition tool?

NCT02110225

LUMOS

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of
rhNGF in Patients With Retinitis Pigmentosa (RP)

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2014-01-01
  • Closing Date: 2015-11-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: